Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)
Clinical trial NCT01613846 · COMPLETED
Trial details
- NCT number
- NCT01613846
- Sponsor
- Technical University of Munich
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-10-30
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.